Periodic Reporting for period 3 - EQIPD (European Quality In Preclinical Data)

The pharmaceutical industry, as well as the advance of biomedical science, depend on robust data and scientific rigor for efficient decision making, patent strength and reduced time-to-market, which in turn determines knowledge gain and availability of new treatments to...